Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.
Published August 15, 2018 · Recall initiated: August 1, 2018
Summary
FDA records drug Class III recall D-1035-2018, published August 15, 2018 and initiated August 1, 2018. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 106,320 bags; Lot: Lot#: A0A0954, A0A0958, A0A0970, Exp 09/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOFLOXACIN
- Manufacturer
- Baxter Healthcare Corporation
- Distributor
- Nationwide USA and Puerto Rico
- UPC
- 0336000047241
- Lot
- Lot#: A0A0954, A0A0958, A0A0970, Exp 09/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevofloxacin Tablets, 500 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6352-61June 15, 2022
- FDALevofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) 24x100 mL Single Dose FlexibleJune 2, 2021
- FDALevofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDCOctober 3, 2018
- FDALevofloxacin Injection in 5% Dextrose, 750 mg (5 mg/mL), 750 mg in 150 mL 5% Dextrose, 150 mL Single UseAugust 15, 2018
- FDALevofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL), 250 mg in 50 mL 5% Dextrose, 50 mL Single UseAugust 15, 2018
- FDAMAYFIELD SPINE TABLE ADAPTOR RADIOLUCENT, Part Number A2600R The MAYFIELD® Infinity XR2 Base Unit is intendedAugust 8, 2018
Questions about this recall
Was Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24. recalled?
Yes. FDA published recall D-1035-2018 on August 15, 2018. Reported hazard: Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOFLOXACIN. UPC: 0336000047241.